Argenica Therapeutics LtdASX: AGN

Successful Completion of Phase 1 Clinical Trial Dosing

Dec 21, 2022 at 2:40 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment